| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 134 | 1.422 | 4.058 | 4.387 | 19.950 | 6.367 | 1.460 | 2.062 | 3.217 |
| Total Income - EUR | 0 | 134 | 1.439 | 4.066 | 14.111 | 23.042 | 16.164 | 1.460 | 2.062 | 3.218 |
| Total Expenses - EUR | 2.849 | 1.933 | 4.234 | 4.751 | 13.366 | 19.908 | 7.877 | 4.040 | 13.483 | 15.821 |
| Gross Profit/Loss - EUR | -2.849 | -1.799 | -2.795 | -686 | 745 | 3.134 | 8.287 | -2.580 | -11.421 | -12.603 |
| Net Profit/Loss - EUR | -2.849 | -1.803 | -2.838 | -807 | 325 | 2.461 | 7.802 | -2.609 | -11.442 | -12.603 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Pharm Impex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 19.763 | 19.388 | 45.292 | 45.433 | 45.295 | 45.042 |
| Current Assets | 3.182 | 2.676 | 4.519 | 2.308 | 6.444 | 8.644 | 5.688 | 9.086 | 7.171 | 7.586 |
| Inventories | 0 | 0 | 802 | 0 | 1.750 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.321 | 2.289 | 3.072 | 1.976 | 3.700 | 9.153 | 6.299 | 8.283 | 7.656 | 7.593 |
| Cash | 862 | 387 | 644 | 331 | 994 | -509 | -611 | 803 | -486 | -6 |
| Shareholders Funds | -12.562 | -14.235 | -16.832 | -17.330 | -16.670 | -13.893 | -7.618 | -10.251 | -21.661 | -34.143 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 15.744 | 16.911 | 21.351 | 19.638 | 42.878 | 41.925 | 58.598 | 64.769 | 74.127 | 86.771 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4712 - 4712" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Pharm Impex Srl